Company intelligence / Profile preview

Catch Bio

Illinois, United States

Ownership: Private
Development stage: Other

Overview

Catch uses machine learning to ingest clinical cancer research from thousands of journals and studies, modeling individual cancer risk against data from the world's largest longitudinal study on cancer incidence. The platform demonstrates that over 50% of cancer risk is driven by modifiable lifestyle and environmental factors rather than genetics alone, and can reduce overall cancer risk up to 60% through personalized interventions

Therapeutic areas: Oncology
Modalities: Biomarker testingAI-powered risk assessment (non-pharmacological diagnostic platform)
Industry: Digital Health Medical Devices

Partnerships

Rhythm Biosciences (US marketing partnership for blood test expansion)

Beyond the preview

Go deeper on Catch Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catch Bio.

Explore the full profile